PFG Investments LLC Has $1.19 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

PFG Investments LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,657 shares of the financial services provider’s stock after selling 607 shares during the quarter. PFG Investments LLC’s holdings in iShares Biotechnology ETF were worth $1,188,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in IBB. Future Financial Wealth Managment LLC bought a new stake in iShares Biotechnology ETF in the first quarter worth approximately $27,000. Bbjs Financial Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $31,000. Pacifica Partners Inc. increased its holdings in shares of iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares in the last quarter. Crewe Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 78 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the first quarter valued at approximately $37,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $144.53 on Tuesday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.17. The business has a 50 day moving average price of $144.27 and a 200-day moving average price of $138.08.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.